Arvinas is a biotechnology company focused on developing innovative therapies using its proprietary PROTAC protein degradation platform, aiming to transform drug discovery and improve patient outcomes in oncology and neurology
Arvinas is a biotechnology company focused on developing innovative therapies using its proprietary PROTAC protein degradation platform, aiming to transform drug discovery and improve patient outcomes in oncology and neurology.